Cellular pathology technique: evolution of a UK NEQAS scheme
Despite the effects of the current pandemic, continued success is key for the UK NEQAS Cellular Pathology Technique EQA scheme, as Chantell Hodgson explains.
This story is Premium Content and is only available to registered users. Please log in to view the full text. If you don't already have an account, please register with us completely free of charge.